Global Single Gene Genetic Disease Screening Services Market Strategic Research Report

Scope of the Report

The global Single Gene Genetic Disease Screening Services market size is predicted to grow from US$ 1,189 million in 2025 to US$ 1,946 million in 2032; it is expected to grow at a CAGR of 7.4% from 2026 to 2032.

Single Gene Genetic Disease Screening Services are clinical testing services designed to analyze a specific gene to determine the presence or absence of pathogenic variants associated with a particular inherited disorder. These services are used for targeted screening, confirmatory testing, or family cascade testing in cases where a specific condition is suspected, enabling clinicians and patients to assess inherited risk, guide reproductive or clinical decisions, and plan appropriate follow-up care.

The single gene genetic disease screening services market occupies a targeted and clinically driven niche within the broader genetic testing landscape, where demand is shaped more by medical decision points than by population-scale screening initiatives. Utilization is typically triggered by family history, known pathogenic variants, positive results from broader screening, or specific clinical suspicion, which gives the market a steadier but less explosive growth profile than panel-based screening. Competitive differentiation centers on analytical accuracy, depth of variant interpretation, turnaround time, and the ability to support clinicians with clear reporting and follow-up pathways, including cascade testing and confirmatory workflows. Over time, the market is likely to remain resilient as a necessary complement to expanded screening and sequencing programs, even as standalone volumes face pressure from multi-gene panels that can reduce the need for isolated single-gene tests in some care settings.

This report presents a comprehensive overview of the global Single Gene Genetic Disease Screening Services market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• NGS
• Whole Exome Sequencing
• Others

Segment by Screening Timing

• Preconception Screening
• Prenatal Screening
• Newborn Screening
• Others

Segment by Sample Type

• Blood-based DNA
• Saliva DNA
• Others

Segment by Application

• Couple
• Individual

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Single Gene Genetic Disease Screening Services market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Couple, Individual evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact